These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25982491)

  • 21. Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose?
    Bannwarth B
    Drugs; 2012 Sep; 72(13):1713-23. PubMed ID: 22931520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical opioid use among oral and intravenous users in Australia: A qualitative comparative study.
    Dertadian G; Iversen J; Dixon TC; Sotiropoulos K; Maher L
    Int J Drug Policy; 2017 Mar; 41():51-58. PubMed ID: 28107670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examining opioid-involved overdose mortality trends prior to fentanyl: New York City, 2000-2015.
    Tuazon E; Kunins HV; Allen B; Paone D
    Drug Alcohol Depend; 2019 Dec; 205():107614. PubMed ID: 31689642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of abuse among unintentional pharmaceutical overdose fatalities.
    Hall AJ; Logan JE; Toblin RL; Kaplan JA; Kraner JC; Bixler D; Crosby AE; Paulozzi LJ
    JAMA; 2008 Dec; 300(22):2613-20. PubMed ID: 19066381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009.
    Calcaterra S; Glanz J; Binswanger IA
    Drug Alcohol Depend; 2013 Aug; 131(3):263-70. PubMed ID: 23294765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High enhancer, downer, withdrawal helper: Multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City.
    Mateu-Gelabert P; Jessell L; Goodbody E; Kim D; Gile K; Teubl J; Syckes C; Ruggles K; Lazar J; Friedman S; Guarino H
    Int J Drug Policy; 2017 Aug; 46():17-27. PubMed ID: 28577506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing trend in accidental pharmaceutical opioid overdose deaths and diverging overdose death correlates following the opioid prescription policy liberalization in Norway 2010-2018.
    Gjersing L; Amundsen E
    Int J Drug Policy; 2022 Oct; 108():103785. PubMed ID: 35907371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid Analgesics in Georgia Medicaid: Trends in Potential Inappropriate Prescribing Practices by Demographic Characteristics, 2009-2014.
    Jayawardhana J; Abraham AJ; Perri M
    J Manag Care Spec Pharm; 2018 Sep; 24(9):886-894. PubMed ID: 30156455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.
    Park JN; Rouhani S; Beletsky L; Vincent L; Saloner B; Sherman SG
    Milbank Q; 2020 Sep; 98(3):700-746. PubMed ID: 32808709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accurate identification of opioid overdose deaths using coronial data.
    Roxburgh A; Pilgrim JL; Hall WD; Burns L; Degenhardt L
    Forensic Sci Int; 2018 Jun; 287():40-46. PubMed ID: 29627712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unintentional opioid overdose deaths in New York City, 2005-2010: a place-based approach to reduce risk.
    Siegler A; Tuazon E; Bradley O'Brien D; Paone D
    Int J Drug Policy; 2014 May; 25(3):569-74. PubMed ID: 24412006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
    Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE
    Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Abuse-Deterrent or Tamper-Resistant Opioid Formulations on Overall Health Care Expenditures in a State Medicaid Program.
    Keast SL; Owora A; Nesser N; Farmer K
    J Manag Care Spec Pharm; 2016 Apr; 22(4):347-56. PubMed ID: 27023688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State-level and system-level opioid prescribing policies: The impact on provider practices and overdose deaths, a systematic review.
    Beaudoin FL; Banerjee GN; Mello MJ
    J Opioid Manag; 2016; 12(2):109-18. PubMed ID: 27194195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths.
    Barocas JA; Wang J; Marshall BDL; LaRochelle MR; Bettano A; Bernson D; Beckwith CG; Linas BP; Walley AY
    Drug Alcohol Depend; 2019 Jul; 200():59-63. PubMed ID: 31100636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dynamic model of the opioid drug epidemic with implications for policy.
    Homer J; Wakeland W
    Am J Drug Alcohol Abuse; 2021 Jan; 47(1):5-15. PubMed ID: 32515234
    [No Abstract]   [Full Text] [Related]  

  • 37. Fentanyl and the Evolving Opioid Epidemic: What Strategies Should Policy Makers Consider?
    Barry CL
    Psychiatr Serv; 2018 Jan; 69(1):100-103. PubMed ID: 28967324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shifting characteristics of nonmedical prescription tranquilizer users in the United States, 2005-2014.
    Palamar JJ; Han BH; Martins SS
    Drug Alcohol Depend; 2019 Feb; 195():1-5. PubMed ID: 30553910
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.